Designed for precise quantitative determination of lidocaine levels in human serum or plasma, the QMS® Lidocaine assay facilitates accurate diagnosis and management of lidocaine overdose, as well as monitoring therapeutic lidocaine levels in clinical settings.
Offers a cost-effective, labor-saving alternative to traditional HPLC or LCMS methods, leveraging competitive inhibition immunoassay technology for efficient drug monitoring.
Compatible with a wide range of automated clinical chemistry analyzers, this assay kit streamlines workflow in medical laboratories, ensuring rapid and reliable lidocaine quantification.
